5-[2-(2-azabicyclo[2.1.1]hexan-2-yl)pyrimidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;1-(3-methylpyrrolidin-1-yl)ethanone
C22H27F3N6O — CID 144739911
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[2-(2-azabicyclo[2.1.1]hexan-2-yl)pyrimidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;1-(3-methylpyrrolidin-1-yl)ethanone
5-[2-(2-azabicyclo[2.1.1]hexan-2-yl)pyrimidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;1-(3-methylpyrrolidin-1-yl)ethanone (PubChem CID 144739911) has the molecular formula C22H27F3N6O and a molecular weight of 448.49 g/mol. Its IUPAC name is 5-[2-(2-azabicyclo[2.1.1]hexan-2-yl)pyrimidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;1-(3-methylpyrrolidin-1-yl)ethanone.
Molecular Properties
| Compound Name | 5-[2-(2-azabicyclo[2.1.1]hexan-2-yl)pyrimidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;1-(3-methylpyrrolidin-1-yl)ethanone |
|---|---|
| PubChem CID | 144739911 |
| Molecular Formula | C22H27F3N6O |
| Molecular Weight | 448.49 g/mol |
| Exact Mass | 448.22 |
| IUPAC Name | 5-[2-(2-azabicyclo[2.1.1]hexan-2-yl)pyrimidin-4-yl]-3-(trifluoromethyl)pyridin-2-amine;1-(3-methylpyrrolidin-1-yl)ethanone |
| SMILES | CC(=O)N1CCC(C)C1.Nc1ncc(-c2ccnc(N3CC4CC3C4)n2)cc1C(F)(F)F |
| InChI | InChI=1S/C15H14F3N5.C7H13NO/c16-15(17,18)11-5-9(6-21-13(11)19)12-1-2-20-14(22-12)23-7-8-3-10(23)4-8;1-6-3-4-8(5-6)7(2)9/h1-2,5-6,8,10H,3-4,7H2,(H2,19,21);6H,3-5H2,1-2H3 |
| InChIKey | AZBPPYDGEREEIY-UHFFFAOYSA-N |
| XLogP | 3.61 |
| TPSA | 88.24 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 448.49 |
| LogP ≤ 5 | 3.61 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 144739911 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.